Decheng Capital and affiliated reporting persons filed Amendment No. 4 to Schedule 13G with the SEC on October 29, 2026, disclosing beneficial ownership positions in BeyondSpring Inc. as of September 30, 2026.

Key Highlights

  • Xiangmin Cui total stake: Dr. Cui reported shared beneficial ownership of 3,065,702 ordinary shares, representing 7.5% of the class.
  • Fund III position: Decheng Capital China Life Sciences USD Fund III, L.P. reported 1,448,293 ordinary shares beneficially owned, or 3.5% of the class.
  • Fund II position: Decheng Capital China Life Sciences USD Fund II, L.P. reported 1,617,409 ordinary shares beneficially owned, or 3.9% of the class.
  • Healthcare fund: Decheng Capital Global Healthcare Fund (Master), LP and its general partner each reported 0.00 shares and 0.0% of the class.
  • Shares outstanding basis: Percentage calculations are based on 41,119,820 ordinary shares outstanding as of August 24, 2026, as reported in BeyondSpring's definitive proxy statement filed September 3, 2026.
  • No sole voting or dispositive power: All reporting persons reported 0.00 shares with sole voting power or sole dispositive power; all ownership is shared.

Decheng Capital's Schedule 13G/A: Ownership Structure in BeyondSpring as of September 30, 2026

According to the filing, seven reporting persons are covered by this Amendment No. 4 to Schedule 13G: Decheng Capital China Life Sciences USD Fund II, L.P. (Fund II); Decheng Capital Management II (Cayman), LLC (GP II); Decheng Capital China Life Sciences USD Fund III, L.P. (Fund III); Decheng Capital Management III (Cayman), LLC (GP III); Decheng Capital Global Healthcare Fund (Master), LP; Decheng Capital Global Healthcare GP, LLC; and Xiangmin Cui. The filing notes that "the Reporting Persons expressly disclaim status as a 'group' for purposes of this Schedule 13G/A."

The filing discloses that BeyondSpring's ordinary shares held in this reporting group consist of 1,448,293 shares held directly by Fund III and 1,617,409 shares held directly by Fund II. According to the filing, GP II is the general partner of Fund II and shares voting and investment authority over Fund II's shares, while GP III is the general partner of Fund III and shares voting and investment authority over Fund III's shares. Dr. Cui is described as "the sole manager of each of GP II and GP III" and shares voting and investment authority over shares held by both funds, giving him aggregate shared beneficial ownership of 3,065,702 shares, or 7.5% of the class.

The securities covered are ordinary shares of BeyondSpring Inc. (NASDAQ:BYSI), par value $0.0001 per share, with CUSIP number G10830100. All reporting entities except Dr. Cui are organized in the Cayman Islands. The filing's triggering event date is listed as September 30, 2026, and the issuer's principal executive offices are listed as 100 Campus Drive, West Side, 4th Floor, Suite 410, Florham Park, NJ, 07932.

What Was Disclosed

Decheng Capital and related entities filed an amended Schedule 13G reporting aggregate shared beneficial ownership of BeyondSpring ordinary shares as of September 30, 2026, with Xiangmin Cui holding the largest reported position at 3,065,702 shares, or 7.5% of the class.